Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Anatomic Stage IV Breast Cancer AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Hematopoietic and Lymphoid Cell Neoplasm|Hormone Receptor Positive Breast Adenocarcinoma|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Malignant Neoplasm in the Brain|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Triple-Negative Breast Carcinoma|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8
Interventions: DRUG: Bintrafusp Alfa|DRUG: Pimasertib|OTHER: Quality-of-Life Assessment
Sponsor: M.D. Anderson Cancer Center